• Je něco špatně v tomto záznamu ?

Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB

M. Bielaszewska, M. Marejková, A. Bauwens, L. Kunsmann-Prokscha, A. Mellmann, H. Karch,

. 2018 ; 308 (7) : 882-889. [pub] 20180619

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012593

Proinflammatory cytokines play important roles in the pathogenesis of diseases caused by enterohemorrhagic Escherichia coli (EHEC) O157, but the spectrum of bacterial components involved in the proinflammatory responses is not fully understood. Here, we investigated the abilities of outer membrane vesicles (OMVs), nanoparticles released by EHEC O157 during growth, to induce production of proinflammatory cytokines in human intestinal epithelial cells. OMVs from both EHEC O157:H7 and sorbitol-fermenting (SF) EHEC O157:H- induced production of interleukin-8 (IL-8) in Caco-2, HCT-8, and HT-29 intestinal epithelial cell lines. H7 flagellin was the key IL-8-inducing component of EHEC O157:H7 OMVs, whereas cytolethal distending toxin V and O157 lipopolysaccharide (LPS) largely contributed to IL-8 production elicited by flagellin-lacking OMVs from SF EHEC O157:H-. The H7 flagellin-mediated signaling via Toll-like receptor (TLR) 5, and O157 LPS-mediated signaling via TLR4/MD-2 complex, which were followed by activation of the nuclear factor NF-κB were major pathways underlying IL-8 production induced by EHEC O157 OMVs. The proinflammatory and immunomodulatory capacities of EHEC O157 OMVs have pathogenetic implications and support the OMVs as suitable vaccine candidates.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012593
003      
CZ-PrNML
005      
20190412095115.0
007      
ta
008      
190405s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijmm.2018.06.004 $2 doi
035    __
$a (PubMed)29934223
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Bielaszewska, Martina $u Institute for Hygiene and the National Consulting Laboratory for Hemolytic Uremic Syndrome, University of Münster, Münster, 48149, Germany; National Institute of Public Health, National Reference Laboratory for E. coli and Shigella, Prague, 100 42, Czech Republic. Electronic address: martina.bielaszewska@szu.cz.
245    10
$a Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB / $c M. Bielaszewska, M. Marejková, A. Bauwens, L. Kunsmann-Prokscha, A. Mellmann, H. Karch,
520    9_
$a Proinflammatory cytokines play important roles in the pathogenesis of diseases caused by enterohemorrhagic Escherichia coli (EHEC) O157, but the spectrum of bacterial components involved in the proinflammatory responses is not fully understood. Here, we investigated the abilities of outer membrane vesicles (OMVs), nanoparticles released by EHEC O157 during growth, to induce production of proinflammatory cytokines in human intestinal epithelial cells. OMVs from both EHEC O157:H7 and sorbitol-fermenting (SF) EHEC O157:H- induced production of interleukin-8 (IL-8) in Caco-2, HCT-8, and HT-29 intestinal epithelial cell lines. H7 flagellin was the key IL-8-inducing component of EHEC O157:H7 OMVs, whereas cytolethal distending toxin V and O157 lipopolysaccharide (LPS) largely contributed to IL-8 production elicited by flagellin-lacking OMVs from SF EHEC O157:H-. The H7 flagellin-mediated signaling via Toll-like receptor (TLR) 5, and O157 LPS-mediated signaling via TLR4/MD-2 complex, which were followed by activation of the nuclear factor NF-κB were major pathways underlying IL-8 production induced by EHEC O157 OMVs. The proinflammatory and immunomodulatory capacities of EHEC O157 OMVs have pathogenetic implications and support the OMVs as suitable vaccine candidates.
650    _2
$a proteiny vnější bakteriální membrány $x metabolismus $7 D001425
650    _2
$a Caco-2 buňky $7 D018938
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčná membrána $x metabolismus $7 D002462
650    _2
$a epitelové buňky $x metabolismus $7 D004847
650    _2
$a infekce vyvolané Escherichia coli $x mikrobiologie $x patologie $7 D004927
650    _2
$a Escherichia coli O157 $x patogenita $7 D019453
650    _2
$a proteiny z Escherichia coli $x metabolismus $7 D029968
650    _2
$a flagelin $x metabolismus $7 D005408
650    _2
$a buňky HT-29 $7 D019073
650    _2
$a lidé $7 D006801
650    _2
$a interleukin-8 $x biosyntéza $7 D016209
650    _2
$a střevní sliznice $x cytologie $x mikrobiologie $x patologie $7 D007413
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a signální transdukce $7 D015398
650    _2
$a toll-like receptor 4 $x metabolismus $7 D051197
650    _2
$a toll-like receptor 5 $x metabolismus $7 D051198
650    _2
$a faktory virulence $x metabolismus $7 D037521
655    _2
$a časopisecké články $7 D016428
700    1_
$a Marejková, Monika $u National Institute of Public Health, National Reference Laboratory for E. coli and Shigella, Prague, 100 42, Czech Republic.
700    1_
$a Bauwens, Andreas $u Institute for Hygiene and the National Consulting Laboratory for Hemolytic Uremic Syndrome, University of Münster, Münster, 48149, Germany.
700    1_
$a Kunsmann-Prokscha, Lisa $u Institute for Hygiene and the National Consulting Laboratory for Hemolytic Uremic Syndrome, University of Münster, Münster, 48149, Germany.
700    1_
$a Mellmann, Alexander $u Institute for Hygiene and the National Consulting Laboratory for Hemolytic Uremic Syndrome, University of Münster, Münster, 48149, Germany; Interdisciplinary Center for Clinical Research (IZKF), University of Münster, Münster, 48149, Germany.
700    1_
$a Karch, Helge $u Institute for Hygiene and the National Consulting Laboratory for Hemolytic Uremic Syndrome, University of Münster, Münster, 48149, Germany; Interdisciplinary Center for Clinical Research (IZKF), University of Münster, Münster, 48149, Germany.
773    0_
$w MED00005699 $t International journal of medical microbiology IJMM $x 1618-0607 $g Roč. 308, č. 7 (2018), s. 882-889
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29934223 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190412095134 $b ABA008
999    __
$a ok $b bmc $g 1391903 $s 1050898
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 308 $c 7 $d 882-889 $e 20180619 $i 1618-0607 $m International journal of medical microbiology $n Int J Med Microbiol $x MED00005699
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Možnosti archivace